认知障碍的数字治疗:探索创新,挑战和未来前景
Grace Yuange Zang1,2, Keqin Rao2, Jing Wu3
1Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.
Journal of medical Internet research
|June 12, 2025
概括
数字疗法为管理认知障碍提供了新的方法,但整合面临着挑战. 通过协作和以用户为中心的设计来解决这些问题是未来认知健康成功的关键.
科学领域:
- 认知神经科学 认知神经科学
- 数字健康技术 数字健康技术
背景情况:
- 认知神经科学和数字技术的进步正在推动认知障碍的数字治疗方法的采用.
- 数字疗法越来越多地用于认知障碍的评估,干预,管理和监测.
研究的目的:
- 探索用于认知障碍 (CDTx) 数字治疗的创新应用.
- 确定和分析阻碍CDTx.广泛临床整合的关键挑战.
- 为CDTx的未来发展和实施提供战略建议.
主要方法:
- 对当前文献和专家观点的观点分析.
- 检查CDTx定义和多利益相关者协作要求.
- 从临床,政策,用户,伦理和技术角度探讨挑战.
主要成果:
- 数字疗法在认知障碍管理的各个方面表现有前途.
- 在临床实践,政策,用户采用,伦理,隐私和数据集成方面存在重大挑战.
- 多利益相关者协作和以用户为中心的设计对于CDTx的成功至关重要.
结论:
- 战略建议侧重于协作,以用户为中心的设计和AI集成.
- 解决已识别的挑战对于提高CDTx的可扩展性和可持续性至关重要.
- CDTx的未来前景取决于克服整合障碍和利用新兴技术.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
108
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
108
01:29Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
01:30Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
01:28Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
01:30Cognitive Development During Adulthood
68
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
68
01:26Alzheimer's Disease: Overview
452
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
452